News
12-06-2018, 10:15 PM
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
More... (https://www.news-medical.net/news/20181207/New-diagnostic-tools-may-help-identify-breast-cancer-patients-who-could-benefit-from-targeted-therapies.aspx)
More... (https://www.news-medical.net/news/20181207/New-diagnostic-tools-may-help-identify-breast-cancer-patients-who-could-benefit-from-targeted-therapies.aspx)